Evidence for a Potential Role of Metallothioneins in Inflammatory Bowel Diseases
Open Access
- 26 August 2009
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2009, 1-9
Abstract
Inflammatory bowel diseases (IBDs) are a group of chronic, relapsing, immune-mediated disorders of the intestine, including Crohn's disease and ulcerative colitis. Recent studies underscore the importance of the damaged epithelial barrier and the dysregulated innate immune system in their pathogenesis. Metallothioneins (MTs) are a family of small proteins with a high and conserved cysteine content that are rapidly upregulated in response to an inflammatory stimulus. Herein, we review the current knowledge regarding the expression and potential role of MTs in IBD. MTs exert a central position in zinc homeostasis, modulate the activation of the transcription factor nuclear factor (NF)-B, and serve as antioxidants. In addition, MTs could be involved in IBD through their antiapoptotic effects or through specific immunomodulating extracellular effects. Reports on MT expression in IBD are contradictory but clearly demonstrate a deviant MT expression supporting the idea that these aberrations in IBD require further clarification.Keywords
This publication has 104 references indexed in Scilit:
- The Role of Zinc and Metallothionein in the Dextran Sulfate Sodium-Induced Colitis Mouse ModelDigestive Diseases and Sciences, 2007
- Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcomeEuropean Journal of Gastroenterology & Hepatology, 2005
- Zinc-induced NF-κB inhibition can be modulated by changes in the intracellular metallothionein levelToxicology and Applied Pharmacology, 2003
- Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidantsThe Journal of Pathology, 2003
- Oxidative burst and metallothionein as a scavenger in macrophagesImmunology & Cell Biology, 2001
- Sensitivity of Metallothionein-Null Mice to LPS/-Galactosamine-Induced LethalityBiochemical and Biophysical Research Communications, 2001
- Augmented Humoral Immune Function in Metallothionein-Null MiceToxicology and Applied Pharmacology, 2000
- Regulatory role of metallothionein in NF‐κB activationFEBS Letters, 1999
- Altered Plasma and Mucosal Concentrations of Trace Elements and Antioxidants in Active Ulcerative ColitisScandinavian Journal of Gastroenterology, 1998
- Role of reactive oxygen metabolites in experimental colitis.Gut, 1990